Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Prostatic Neoplasms × Cytarabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 174 Leukemia 95 Lymphoma 77 Precursor Cell Lymphoblastic Leukemia-Lymphoma 72 Burkitt Lymphoma 45 Myelodysplastic Syndromes 43 Lymphoma, Mantle-Cell 41 Lymphoma, Large B-Cell, Diffuse 40 Lymphoma, Non-Hodgkin 39 Leukemia, Monocytic, Acute 28 Leukemia, Myelomonocytic, Acute 27 Lymphoma, Follicular 26 Leukemia, Erythroblastic, Acute 23 Recurrence 22 Lymphoma, Large-Cell, Immunoblastic 22 Leukemia, Megakaryoblastic, Acute 22 Congenital Abnormalities 21 Hodgkin Disease 18 Leukemia, Lymphocytic, Chronic, B-Cell 17 Leukemia, Myelomonocytic, Chronic 16 Blast Crisis 15 Anemia, Refractory, with Excess of Blasts 14 Lymphoma, B-Cell, Marginal Zone 13 Myeloproliferative Disorders 11 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11 Dendritic Cell Sarcoma, Interdigitating 11 Multiple Myeloma 10 Leukemia, Myeloid, Chronic-Phase 10 Leukemia, Myeloid, Accelerated Phase 10 Leukemia, Biphenotypic, Acute 10

Interventions

Docetaxel 122 Prednisone 105 Abiraterone Acetate 79 Leuprolide 76 enzalutamide 74 Radiotherapy 49 Goserelin 48 bicalutamide 45 Magnetic Resonance Spectroscopy 45 Androgen Antagonists 42 apalutamide 39 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 39 Radiosurgery 30 abiraterone 29 cabazitaxel 28 Gonadotropin-Releasing Hormone 26 Specimen Handling 25 Carboplatin 25 gallium 68 PSMA-11 23 darolutamide 23 Estramustine 22 Metformin 21 luprolide acetate gel depot 20 relugolix 19 Triptorelin Pamoate 19 Radiation 18 Pluvicto 18 Brachytherapy 18 sipuleucel-T 16 prednylidene 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00480090 2019-02-15

SLAP

University Health Network, Toronto

Phase 2 Completed

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡